Atorvastatin [atorvastatin]
- Terms
-
Atoris
atorvastatin vápenatá sůl hydrát
atorvastatin vápenatá sůl trihydrát
atorvastatin vápenatý
atorvastatin vápenatý anhydrát
atorvastatin vápenatý trihydrát
atorvastatin vápník
Sortis
Torvacard
trihydrát atorvastatinu vápenatého
trihydrát hemivápenaté soli atorvastatinu
Tulip
-
(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid
Atorvastatin Calcium
Atorvastatin Calcium Anhydrous
Atorvastatin Calcium Hydrate
Atorvastatin Calcium Trihydrate
Atorvastatin, Calcium Salt
CI 981
CI-981
Lipitor
Liptonorm
A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.
- DUI
- D000069059 MeSH Browser
- CUI
- M0179294
- History note
- 2019 (1990)
- Public note
- 2019; see ATORVASTATIN CALCIUM 2016-2018; ATORVASTATIN CALCIUM was indexed under HEPTANOIC ACIDS and PYRROLES 1990-2015
Allowable subheadings
- AD
- administration & dosage 38
- AE
- adverse effects 12
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis 1
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 1
- CL
- classification
- EC
- economics 2
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 1
- PK
- pharmacokinetics 4
- PD
- pharmacology 34
- PO
- poisoning 1
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 73
- TO
- toxicity
- UR
- urine